COCP
NASDAQ
$0.93
Cocrystal Pharma Inc (COCP)
Cocrystal Pharma, Inc., a biotechnology company, is focused on the discovery and development of antiviral therapeutic treatments for serious and / or chronic viral diseases. The company is headquartered in Bothell, Washington.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9 (+867.64%)
Market Cap
$13M
Free Cash Flow Yield
-57.46%
Beta (5Y)
0.69
Price Chart
Valuation
Market Cap$13M
P/S58.22
P/B3.22
Profitability
Total Revenue (TTM)$225K
Gross Profit (TTM)-$4.84M
EBITDA-$8.97M
Operating Margin-1047%
EPS-$0.70
Financial Health
Free Cash Flow Yield-57.46%
Growth & Risk
EPS 5Y CAGR-18.79%
Revenue 5Y CAGR-32.05%
FCF 5Y CAGR-4.52%
Beta (5Y)0.69
Sharpe Ratio-0.46